Thursday
Mar152012
Discovery Labs ($DSCO): No Hesitation, Discovery Is Raising Dollars in the wake of Good FDA News
Discovery Labs ($DSCO) announces proposed public offering of undetermined amounce of common stock through Lazard.
Lazard Capital Markets LLC is acting as the sole book-running manager for the offering, Stifel Nicolaus Weisel is acting as co-lead manager, and ROTH Capital Partners, LLC is acting as co-manager , see ournote from earlier in the week regarding Surfaxin, 4th times a charm.
tagged
dsco,
lazard |
Print Article
Email Article Posted on
Thursday, March 15, 2012 at 4:08PM
Permalink in
Specialty Pharma







Reader Comments